iTeos Therapeutics (ITOS) Insider Trading & Ownership $8.22 -0.13 (-1.56%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$8.40 +0.18 (+2.18%) As of 05/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock iTeos Therapeutics (NASDAQ:ITOS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$38,650.00Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$13.40 M Get ITOS Insider Trade Alerts Want to know when executives and insiders are buying or selling iTeos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ITOS Insider Buying and Selling by Quarter iTeos Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/13/2025Ansbert GadickeMajor ShareholderSell1,031,931$8.06$8,317,363.86 5/13/2025Bioventures 2018 L.P. MpmMajor ShareholderSell630,191$8.06$5,079,339.46 11/19/2024Matthew GallCFOBuy5,000$7.73$38,650.00 (Data available from 1/1/2013 forward) ITOS Insider Trading Activity - Frequently Asked Questions Who is on iTeos Therapeutics's Insider Roster? The list of insiders at iTeos Therapeutics includes Ansbert Gadicke, Bioventures 2018 L.P. Mpm, Boxer Capital, Llc, David Hallal, and Matthew Gall. Learn more on insiders at ITOS. What percentage of iTeos Therapeutics stock is owned by insiders? 12.50% of iTeos Therapeutics stock is owned by insiders. Learn more on ITOS's insider holdings. Which iTeos Therapeutics insiders have been buying company stock? The following insider purchased ITOS shares in the last 24 months: Matthew Gall ($80,500.00). How much insider buying is happening at iTeos Therapeutics? Insiders have purchased a total of 10,000 ITOS shares in the last 24 months for a total of $80,500.00 bought. Which iTeos Therapeutics insiders have been selling company stock? The following insiders have sold ITOS shares in the last 24 months: Ansbert Gadicke ($8,317,363.86), Bioventures 2018 L.P. Mpm ($5,079,339.46), and Boxer Capital, Llc ($5,691,000.00). How much insider selling is happening at iTeos Therapeutics? Insiders have sold a total of 2,012,122 iTeos Therapeutics shares in the last 24 months for a total of $19,087,703.32 sold. iTeos Therapeutics Key ExecutivesDr. Michel Detheux Ph.D. (Age 57)President, CEO & Director Compensation: $1.04MMr. Matthew Gall (Age 47)Chief Financial Officer Compensation: $648kMr. Matthew A. Call M.B.A. (Age 51)Chief Operating Officer Compensation: $706.21kDr. Yvonne McGrath Ph.D. (Age 50)Chief Scientific Officer Ms. Adi OsovskyExecutive Vice President of LegalMr. Philippe BrantegemExecutive Vice President of Human ResourcesDr. Joyson Joseph Karakunnel FACP (Age 53)M.D., M.Sc., Interim Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies WVE Insider Trading GYRE Insider Trading PAHC Insider Trading MLYS Insider Trading COLL Insider Trading SNDX Insider Trading RCUS Insider Trading ELVN Insider Trading AVDL Insider Trading SYRE Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite This page (NASDAQ:ITOS) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iTeos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iTeos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ITOS Stock Free ITOS Stock Alerts